Shanxi Zhendong PharmaceuticalLtd Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Lianmin Yang
Chief executive officer
CN¥678.5k
Total compensation
CEO salary percentage | n/a |
CEO tenure | 3yrs |
CEO ownership | n/a |
Management average tenure | 3yrs |
Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO
Lianmin Yang (61 yo)
3yrs
Tenure
CN¥678,500
Compensation
Mr. Lianmin Yang is President of Shanxi Zhendong Pharmaceutical Co.,Ltd from December 02, 2021 and had been its Deputy General Manager since April 24, 2021 and serves as its Director. He has M.B.A. from Ch...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Director | 3yrs | CN¥678.50k | no data | |
Head of Accounting & CFO | 6.2yrs | CN¥375.40k | no data | |
VP & Secretary of the Board of Director | 1.6yrs | CN¥521.50k | no data | |
Executive GM & Director | no data | no data | no data |
3.0yrs
Average Tenure
40yo
Average Age
Experienced Management: 300158's management team is considered experienced (3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Director | no data | CN¥678.50k | no data | |
Executive GM & Director | 1.7yrs | no data | no data | |
Supervisor | 13yrs | no data | 0.077% CN¥ 3.4m | |
Chairman of the Supervisory Board | 16yrs | no data | 0.084% CN¥ 3.7m | |
Director | 16yrs | CN¥83.30k | no data | |
Director | 6.4yrs | CN¥694.70k | no data | |
Director | 2.7yrs | CN¥688.30k | no data | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Independent Director | 9.5yrs | no data | no data | |
Non-Independent Director | less than a year | no data | no data | |
Supervisor | less than a year | no data | no data |
2.7yrs
Average Tenure
60yo
Average Age
Experienced Board: 300158's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 11:05 |
End of Day Share Price | 2024/12/26 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanxi Zhendong Pharmaceutical Co.,Ltd is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Wenchao Jiao | Ping An Securities Co. Ltd. |
Yin Ye | Ping An Securities Co. Ltd. |
Wen Qing Wei | Shenwan Hongyuan Securities |